Clinical Trials on Mosquito-Borne Disease in Australia

Total 13529 results

Medical University of Vienna
Surgebright Gmbh

Recruiting

Human Bone Graft in Epiphysiodesis

Leg Length Differences | Primordial Gigantism

Austria
Kirby Institute

Recruiting

Real World Assessment of People Living With Chronic Hepatitis B in Australia (REACH-B)

Hepatitis B

Australia
Kirby Institute

Recruiting

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs (TOPIC)

Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Arrowhead Pharmaceuticals

Withdrawn

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Chronic Hepatitis B

Australia
Oligo Medic Pty Ltd
Mobius Medical Pty Ltd.

Recruiting

A Comparison of JointRep® and Microfracture in Repair of Cartilage Lesions on the Femoral Condyle or Trochlea, (JMAC)

Chondral Defect | Articular Cartilage Disorder of Knee | Articular Cartilage Defect

Australia, Canada
Kirby Institute

Completed

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

HIV Infections

Australia
Bayside Health

Completed

Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?

Fractured Hip

Australia
University of Melbourne
Melbourne Health; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Effect of High Dose Vitamin D Supplementation on HIV Latency (VIVA)

Human Immunodeficiency Virus

Australia
BioMarin Pharmaceutical

Active, not recruiting

A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia

Achondroplasia

Australia, United Kingdom
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
Medical University of Vienna

Completed

The Longitudinal PTH-Study

Secondary Hyperparathyroidism | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | Kidney Replacement

Austria
Sydney South West Area Health Service
St George Hospital, Australia; University of Wollongong; South West Sydney Local... and other collaborators

Unknown

Pulsed Electromagnetic Field (PEMF) Stimulation for Tibia Fractures

Tibial Fractures

Australia
Kirby Institute

Completed

Hepatitis B Acceptability and Vaccination Incentive Trial (HAVIT)

Hepatitis B

Australia
bioLytical Laboratories
St Vincent's Hospital Melbourne

Not yet recruiting

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Hepatitis B | Hepatitis B Infection

Australia
American College of Radiology - Image Metrix
World Molecular Imaging Society

Unknown

F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets

Bone Metastases

United States, Australia, Austria, Portugal, Switzerland
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia

Myelodysplasia

Australia
Kirby Institute
Bristol-Myers Squibb

Withdrawn

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism (HEPCOG-II)

Hepatitis C, Chronic

Australia
Kirby Institute

Completed

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)

Hepatitis C, Chronic

Australia
Holdsworth House Medical Practice
Atomo Diagnostics

Completed

Performance and Usability Evaluation of the Atomo HIV Self-Test

HIV Infections

Australia
Kirby Institute
Hoffmann-La Roche

Completed

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study (ASK-500)

HIV Infections

Australia
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Australia
Andrew Carr
Merck Sharp & Dohme LLC

Completed

Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men (RAL-NPEP)

HIV Infections | HIV Prevention

Australia
University of Dundee
Burnet Institute; Public Health Wales

Completed

Reaching mEthadone Users Attending Community pHarmacies With HCV (REACH HCV)

Hepatitis C

Australia, United Kingdom
Kirby Institute

Completed

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (SHARP-P)

Hepatitis C, Chronic

Australia
Kirby Institute

Completed

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (ENCORE1)

HIV Infections

Australia
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
Medical University of Graz

Completed

Role of Comorbidities in Chronic Heart Failure Study (RoC-HF)

Heart Failure | Osteoporosis | Osteoporotic Fractures | Pulse Wave Analysis | Blood Pressure Monitoring, Ambulatory | Comorbidity

Austria
Pfizer

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Tick-borne Encephalitis

Austria, Germany, Poland
Clinuvel Pharmaceuticals Limited

Completed

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

Polymorphic Light Eruption (PLE)

Austria, Australia, United Kingdom
GlaxoSmithKline

Completed

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Neisseria Meningitidis | Haemophilus Influenzae Type b

Australia
Azora Therapeutics Australia Pty Ltd

Completed

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

Australia
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Influenza

Australia, Singapore
Novartis

Completed

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Myelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare Anaemias

Australia
Kirby Institute

Withdrawn

Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays

Hepatitis B

Australia
Kirby Institute
University of Public Health, Myanmar

Completed

Simplified Monitoring Myanmar SM2 Study (SM2)

HIV Infections | Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Seqirus

Completed

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

Influenza

Australia
Kira Pharmacenticals (US), LLC.

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Paroxysmal Nocturnal Hemoglobinuria

Australia
Eli Lilly and Company

Completed

Bone Effects of Teriparatide Following Alendronate

Osteoporosis

Austria, Czech Republic
EpiAxis Therapeutics
The Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...

Completed

An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer (Epi-PRIMED)

Metastatic Breast Cancer

Australia
Sanofi
Regeneron Pharmaceuticals

Terminated

Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis (SUSTAIN)

Ankylosing Spondylitis

United States, France, Canada, Poland, Netherlands, Spain, Belgium, Hungary, Lithuania, Austria, Czechia, Australia
AOP Orphan Pharmaceuticals AG

Completed

Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera (PEGINVERA)

Polycythemia Vera

Austria
Sanofi

Completed

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

Japanese Encephalitis | Yellow Fever

Australia
Kirby Institute

Completed

Raltegravir and Atazanavir Dosing Strategy Study (SPARTA)

HIV Infection

Australia
Kirby Institute

Completed

Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C)

Hepatitis C

Australia
Kirby Institute

Completed

A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use (SIMPLIFY)

Hepatitis C

Australia
IlluminOss Medical, Inc.

Completed

A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease

Humerus Pathological Fracture

Austria, Germany, Netherlands
Kirby Institute

Terminated

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs (DARLO-C)

Hepatitis C

Australia
Otsuka Australia Pharmaceutical Pty Ltd

Completed

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire (TPMQ)

Myelodysplastic Syndrome (MDS)

Australia

Clinical Trials on Mosquito-Borne Disease in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations